At Aragen, we work closely with clients to deliver customized therapeutic cell line development. We specialize in difficult to express proteins, and our mammalian host cell lines are primarily developed in Chinese Hamster Ovary (CHO) cells to produce recombinant protein products of interest. Most clients leverage the decades of experience we have with our inhouse CHO-DG44 platform, which delivers a royalty free, low risk option for the scalable manufacture of proteins within a cGMP environment. We also have significant expertise in multiple mammalian expression platforms, including CHO-S, CHO-GS, and Sigma’s CHOZN.
20+ years experience in executing parallel processing and focused analytics to mitigate risks to client programs and shorten the timeline to IND, with scalable and reproducible processes.
FAQ
Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam, eaque ipsa quae ab illo inventore veritatis et quasi architecto beatae vitae dicta sunt explicabo. Nemo enim ipsam voluptatem quia voluptas sit aspernatur aut odit aut fugit
Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam, eaque ipsa quae ab illo inventore veritatis et quasi architecto beatae vitae dicta sunt explicabo. Nemo enim ipsam voluptatem quia voluptas sit aspernatur aut odit aut fugit
Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam, eaque ipsa quae ab illo inventore veritatis et quasi architecto beatae vitae dicta sunt explicabo. Nemo enim ipsam voluptatem quia voluptas sit aspernatur aut odit aut fugit
